Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aung Naing

Showing results (81-90 of 397) with videos related to

Pageof 40
Sort By:
Journal for Immunotherapy of Cancer|October 16, 2024
First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironmentsAung Naing, Danny Khalil, Oliver Rosen, et al.
Gynecologic Oncology|March 30, 2010
Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experienceJohn Moroney, Jennifer Wheler, David Hong, et al.
Journal of Human Evolution|August 6, 2002
The upper dentition and face of Pondaungia cotteri from central MyanmarNobuo Shigehara, Masanaru Takai, Richard F Kay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
Phase I clinical trial outcomes in 93 patients with brain metastases: the MD anderson cancer center experienceApostolia Maria Tsimberidou, Katherine Letourneau, Sijin Wen, et al.
Journal for Immunotherapy of Cancer|May 5, 2019
Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatmentHamzah Abu-Sbeih, Cynthia Nguyen Tran, Phillip S Ge, et al.
Therapeutic Advances in Medical Oncology|April 29, 2025
ICOS and ICOS ligand: expression patterns and outcomes in oncology patientsMina Nikanjam, Shumei Kato, Daisuke Nishizaki, et al.
Plos One|August 15, 2014
Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumorsYunyun Jiang, Vivek Subbiah, Filip Janku, et al.
International Journal of Cancer|September 8, 2016
Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTERIshwaria M Subbiah, Jennifer J Wheler, Kenneth R Hess, et al.
Clinical Breast Cancer|February 6, 2010
Clinical outcomes of patients with breast cancer in a phase I clinic: the M. D. Anderson cancer center experienceJennifer Wheler, Apostolia M Tsimberidou, Stacy Moulder, et al.
Investigational New Drugs|October 1, 2016
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experienceManojkumar Bupathi, Joud Hajjar, Stacie Bean, et al.
Pageof 40

Showing results (81-90 of 397) with videos related to

Sort By:
Pageof 40
Journal for Immunotherapy of Cancer|October 16, 2024
First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironmentsAung Naing, Danny Khalil, Oliver Rosen, et al.
Gynecologic Oncology|March 30, 2010
Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experienceJohn Moroney, Jennifer Wheler, David Hong, et al.
Journal of Human Evolution|August 6, 2002
The upper dentition and face of Pondaungia cotteri from central MyanmarNobuo Shigehara, Masanaru Takai, Richard F Kay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
Phase I clinical trial outcomes in 93 patients with brain metastases: the MD anderson cancer center experienceApostolia Maria Tsimberidou, Katherine Letourneau, Sijin Wen, et al.
Journal for Immunotherapy of Cancer|May 5, 2019
Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatmentHamzah Abu-Sbeih, Cynthia Nguyen Tran, Phillip S Ge, et al.
Therapeutic Advances in Medical Oncology|April 29, 2025
ICOS and ICOS ligand: expression patterns and outcomes in oncology patientsMina Nikanjam, Shumei Kato, Daisuke Nishizaki, et al.
Plos One|August 15, 2014
Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumorsYunyun Jiang, Vivek Subbiah, Filip Janku, et al.
International Journal of Cancer|September 8, 2016
Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTERIshwaria M Subbiah, Jennifer J Wheler, Kenneth R Hess, et al.
Clinical Breast Cancer|February 6, 2010
Clinical outcomes of patients with breast cancer in a phase I clinic: the M. D. Anderson cancer center experienceJennifer Wheler, Apostolia M Tsimberidou, Stacy Moulder, et al.
Investigational New Drugs|October 1, 2016
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experienceManojkumar Bupathi, Joud Hajjar, Stacie Bean, et al.
Pageof 40